{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:47:17Z","timestamp":1792432037374,"version":"4.5.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>\n                      The field of cystic fibrosis is experiencing dramatic changes, as the translation of a massive body of scientific knowledge accumulated from the day of the cloning of the\n                      <jats:italic toggle=\"yes\">CFTR<\/jats:italic>\n                      gene has led to the identification of effective therapies to correct the basic defect. This has also allowed care providers and people with cystic fibrosis in low-income and middle-income countries (LMICs) to become more knowledgeable and proficient in cystic fibrosis cares.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>This review focuses on two main aspects highly relevant to understand the current status of cystic fibrosis in LMICs: The recognition of the universal occurrence of cystic fibrosis, as well as the varying incidence in different regions of the world, and the collaborative international efforts for dissemination of best care practices as an attempt to close gaps in care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>As the field continues to change rapidly, multiple international efforts are attempting to close gaps and disparities clearly apparent between affluent countries and LMICs. However, these efforts are seriously hampered by limited access to effective therapies and most dramatically to CFTR modulator drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001458","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T09:21:02Z","timestamp":1743672062000},"page":"266-271","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The globalization of cystic fibrosis care"],"prefix":"10.1097","volume":"37","author":[{"given":"Carlos E.","family":"Milla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Children"},{"key":"R6-20250506","first-page":"709","article-title":"Feasibility study of community control programmes for cystic fibrosis: memorandum from a WHO\/ICF(M)A meeting","volume":"68","year":"1990","journal-title":"Bull World Health Organ"},{"key":"R7-20250506","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"R8-20250506","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0168-9525(92)90168-4","article-title":"The spectrum of cystic fibrosis mutations","volume":"8","author":"Tsui","year":"1992","journal-title":"Trends Genet"},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/346366a0","article-title":"A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein","volume":"346","author":"Cutting","year":"1990","journal-title":"Nature"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations-- correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum Mutat"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"9074760","DOI":"10.1155\/2020\/9074760","article-title":"Characterization of ancestral origin of cystic fibrosis of patients with new reported mutations in CFTR","volume":"2020","author":"Paz","year":"2020","journal-title":"Biomed Res Int"},{"key":"R14-20250506","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2353\/jmoldx.2008.080004","article-title":"Multiplex ligation-dependent probe amplification identification of whole exon and single nucleotide deletions in the CFTR gene of Hispanic individuals with cystic fibrosis","volume":"10","author":"Schrijver","year":"2008","journal-title":"J Mol Diagn"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jmoldx.2013.05.006","article-title":"Novel CFTR variants identified during the first 3\u200ayears of cystic fibrosis newborn screening in California","volume":"15","author":"Prach","year":"2013","journal-title":"J Mol Diagn"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"Newborn screening for cystic fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jcf.2006.07.004","article-title":"CFTR gene analysis in Latin American CF patients: heterogeneous origin and distribution of mutations across the continent","volume":"6","author":"P\u00e9rez","year":"2007","journal-title":"J Cyst Fibros"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0039-1678682","article-title":"Homozygous deletion of the CFTR gene caused by interstitial maternal isodisomy in a Peruvian child with cystic fibrosis","volume":"8","author":"V\u00e1squez Sotomayor","year":"2019","journal-title":"J Pediatr Genet"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12920-021-01111-w","article-title":"Frequency of allele variations in the CFTR gene in a Mexican population","volume":"14","author":"Cant\u00fa-Reyna","year":"2021","journal-title":"BMC Med Genomics"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"272.e3","DOI":"10.1016\/j.jpeds.2018.03.047","article-title":"A low-cost and simple genetic screening for cystic fibrosis provided by the Brazilian Public Health System","volume":"199","author":"Rispoli","year":"2018","journal-title":"J Pediatr"},{"key":"R21-20250506","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1399-0004.2002.610307.x","article-title":"Complete screening of the CFTR gene in Argentine cystic fibrosis patients","volume":"61","author":"Visich","year":"2002","journal-title":"Clin Genet"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcf.2020.08.007","article-title":"Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country","volume":"20","author":"da Silva Filho","year":"2021","journal-title":"J Cyst Fibros"},{"key":"R23-20250506","doi-asserted-by":"crossref","first-page":"e00645","DOI":"10.1002\/mgg3.645","article-title":"Identification of a novel large deletion and other copy number variations in the CFTR gene in patients with cystic fibrosis from a multiethnic population","volume":"7","author":"Martins","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"R24-20250506","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s004310051277","article-title":"Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations","volume":"159","author":"Kambouris","year":"2000","journal-title":"Eur J Pediatr"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"103685","DOI":"10.1016\/j.sjbs.2023.103685","article-title":"A comprehensive review of cystic fibrosis in Africa and Asia","volume":"30","author":"Abubakar Bobbo","year":"2023","journal-title":"Saudi J Biol Sci"},{"key":"R26-20250506","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcf.2019.09.007","article-title":"Cystic fibrosis in black African children in South Africa: a case control study","volume":"19","author":"Owusu","year":"2020","journal-title":"J Cyst Fibros"},{"key":"R27-20250506","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1183\/23120541.00856-2020","article-title":"Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome","volume":"7","author":"Zampoli","year":"2021","journal-title":"ERJ Open Res"},{"key":"R28-20250506","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14715\/cmb\/2016.62.13.5","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene mutations in North Egyptian population: implications for the genetic diagnosis in Egypt","volume":"62","author":"El-Seedy","year":"2016","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R29-20250506","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ppul.24299","article-title":"Novel mutations and deletions in cystic fibrosis in a tertiary cystic fibrosis center in Istanbul","volume":"54","author":"Atag","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"R30-20250506","doi-asserted-by":"crossref","first-page":"426","DOI":"10.5152\/TurkThoracJ.2021.20282","article-title":"Association between cystic fibrosis severity markers and CFTR genotypes in Turkish Children","volume":"22","author":"Ba\u015faran","year":"2021","journal-title":"Turk Thorac J"},{"key":"R31-20250506","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ppul.26939","article-title":"Initial characteristics of cystic fibrosis in Algeria: description of 34 pediatric cases","volume":"59","author":"Bendoukha","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"R32-20250506","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2213-2600(12)70057-7","article-title":"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect","volume":"1","author":"Boyle","year":"2013","journal-title":"Lancet Respir Med"},{"key":"R33-20250506","first-page":"219","article-title":"Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis","volume":"31","author":"Jung","year":"2011","journal-title":"Korean J Lab Med"},{"key":"R34-20250506","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/resp.12452","article-title":"Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients","volume":"20","author":"Liu","year":"2015","journal-title":"Respirology"},{"key":"R35-20250506","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/resp.12656","article-title":"Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments","volume":"20","author":"Singh","year":"2015","journal-title":"Respirology"},{"key":"R36-20250506","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.lansea.2024.100434","article-title":"CFTR mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India","volume":"27","author":"Varkki","year":"2024","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"R37-20250506","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/02770903.2023.2297365","article-title":"Exploring the diversity of CFTR gene mutations in cystic fibrosis individuals of South Asia","volume":"61","author":"Rafique","year":"2024","journal-title":"J Asthma"},{"key":"R38-20250506","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/ppul.23539","article-title":"Differences in gene mutations between Chinese and Caucasian cystic fibrosis patients","volume":"52","author":"Zheng","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"R39-20250506","first-page":"544","article-title":"The estimated incidence of cystic fibrosis in Japan","volume":"24","author":"Yamashiro","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R40-20250506","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcf.2007.06.001","article-title":"Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations","volume":"7","author":"Alibakhshi","year":"2008","journal-title":"J Cyst Fibros"},{"key":"R41-20250506","doi-asserted-by":"crossref","first-page":"1140034","DOI":"10.3389\/fgene.2023.1140034","article-title":"Genetic attributes of Iranian cystic fibrosis patients: the diagnostic efficiency of CFTR mutations in over a decade","volume":"14","author":"Hosseini Nami","year":"2023","journal-title":"Front Genet"},{"key":"R42-20250506","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13023-018-0968-2","article-title":"Clinical and genetic characteristics of cystic fibrosis in CHINESE patients: a systemic review of reported cases","volume":"13","author":"Guo","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"R43-20250506","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-022-02279-9","article-title":"Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to Caucasians","volume":"17","author":"Ni","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"R44-20250506","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2012.11.003","article-title":"Phenotypic expression of the 3120+1G>A mutation in non-Caucasian children with cystic fibrosis in South Africa","volume":"12","author":"Masekela","year":"2013","journal-title":"J Cyst Fibros"},{"key":"R45-20250506","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/ppul.24726","article-title":"Lung function determinants and mortality of children and adolescents with cystic fibrosis in South Africa 2007\u20132016","volume":"55","author":"Vandenbroucke","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"R46-20250506","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ppul.25766","article-title":"Predictors of mortality in children with cystic fibrosis in India","volume":"57","author":"Kaur","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"R47-20250506","doi-asserted-by":"crossref","first-page":"eS8","DOI":"10.1016\/S0929-693X(20)30044-0","article-title":"CFTR gene variants, epidemiology and molecular pathology","volume":"27 Suppl 1","author":"Bareil","year":"2020","journal-title":"Arch Pediatr"},{"key":"R48-20250506","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/humu.23276","article-title":"CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants","volume":"38","author":"Claustres","year":"2017","journal-title":"Hum Mutat"},{"key":"R51-20250506","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jcf.2024.02.006","article-title":"In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis","volume":"23","author":"Bihler","year":"2024","journal-title":"J Cystic Fibrosis"},{"key":"R52-20250506","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.gim.2022.06.009","article-title":"CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis","volume":"24","author":"Vaidyanathan","year":"2022","journal-title":"Genet Med"},{"key":"R53-20250506","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations\u2014 correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum Mutat"},{"key":"R54-20250506","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe-where is it worthwhile?","volume":"6","author":"Scotet","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"R55-20250506","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ppul.25130","article-title":"Comparison between two newborn screening strategies for cystic fibrosis in Argentina: IRT\/IRT versus IRT\/PAP","volume":"56","author":"Teper","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R56-20250506","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12687-015-0236-2","article-title":"Ethics, genetics and public policies in Uruguay: newborn and infant screening as a paradigm","volume":"6","author":"Larrandaburu","year":"2015","journal-title":"J Community Genet"},{"key":"R57-20250506","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ajmg.c.31899","article-title":"Newborn screening in Latin America: a brief overview of the state of the art","volume":"187","author":"Borrajo","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R58-20250506","first-page":"1039","article-title":"An indigenously developed method for sweat collection and estimation of chloride for diagnosis of cystic fibrosis","volume":"39","author":"Kabra","year":"2002","journal-title":"Indian Pediatr"},{"key":"R59-20250506","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/ppul.26137","article-title":"Development of algorithm for diagnosis of cystic fibrosis in absence of sweat chloride testing in resource-limited setting","volume":"57","author":"Sahoo","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"R60-20250506","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European Cystic Fibrosis Society standards of care: framework for the cystic fibrosis centre","volume":"13 Suppl 1","author":"Conway","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"(Suppl 1)","key":"R61-20250506","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1136\/bmjqs-2013-002363","article-title":"Improving chronic care delivery and outcomes: the impact of the cystic fibrosis Care Center Network","volume":"23","author":"Mogayzel","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"R62-20250506","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/bmj.316.7147.1771","article-title":"Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study","volume":"316","author":"Mahadeva","year":"1998","journal-title":"BMJ"},{"key":"R63-20250506","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.prrv.2006.04.218","article-title":"Diagnosing and managing cystic fibrosis in the developing world","volume":"7 Suppl 1","author":"Kabra","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"R64-20250506","first-page":"37","article-title":"Cystic fibrosis in low and middle-income countries (LMIC): A view from four different regions of the world","volume":"38","author":"da Silva Filho","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"R65-20250506","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/ppul.27294","article-title":"Challenges in the care of cystic fibrosis in low-to-middle income countries","volume":"60","author":"Kabra","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"R66-20250506","doi-asserted-by":"crossref","first-page":"107821","DOI":"10.1016\/j.rmed.2024.107821","article-title":"Identifying disparities in pediatric cystic fibrosis care between low-middle and middle-high income countries in the Middle East","volume":"234","author":"Saad","year":"2024","journal-title":"Respir Med"},{"key":"R67-20250506","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12038-024-00456-5","article-title":"Diagnosis and treatment of cystic fibrosis in India: what is at stake for developing countries?","volume":"49","author":"Purushothaman","year":"2024","journal-title":"J Biosci"},{"key":"R68-20250506","first-page":"e20220306","article-title":"Patient care in cystic fibrosis centers: a real-world analysis in Brazil","volume":"49","author":"Procianoy","year":"2023","journal-title":"J Bras Pneumol"},{"key":"R69-20250506","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/s1806-37562017000000065","article-title":"Brazilian guidelines for the diagnosis and treatment of cystic fibrosis","volume":"43","author":"Athanazio","year":"2017","journal-title":"J Bras Pneumol"},{"key":"R70-20250506","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13023-024-03506-1","article-title":"Diagnosing cystic fibrosis in low- and middle-income countries: challenges and strategies","volume":"19","author":"Fuhrer","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"R72-20250506","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R73-20250506","doi-asserted-by":"crossref","first-page":"i95","DOI":"10.1136\/bmjqs-2013-002790","article-title":"Accelerating implementation of biomedical research advances: critical elements of a successful 10\u200ayear Cystic Fibrosis Foundation healthcare delivery improvement initiative","volume":"23 Suppl 1","author":"Marshall","year":"2014","journal-title":"BMJ Qual Saf"},{"issue":"(Suppl 1)","key":"R74-20250506","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-017-0745-7","article-title":"Introduction of a collaborative quality improvement program in the French cystic fibrosis network: the PHARE-M initiative","volume":"13","author":"Pougheon Bertrand","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"(Suppl 1)","key":"R75-20250506","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13023-017-0744-8","article-title":"Trans-Atlantic collaboration: applying lessons learned from the US CF Foundation quality improvement initiative","volume":"13","author":"Sabadosa","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"R76-20250506","doi-asserted-by":"crossref","first-page":"e002466","DOI":"10.1136\/bmjoq-2023-002466","article-title":"Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative","volume":"12","author":"List","year":"2023","journal-title":"BMJ Open Qual"},{"key":"R77-20250506","doi-asserted-by":"crossref","first-page":"e10356","DOI":"10.1002\/lrh2.10356","article-title":"The Cystic Fibrosis Learning Network: a mixed methods evaluation of program goals, attributes, and impact","volume":"7","author":"Van Citters","year":"2023","journal-title":"Learn Health Syst"},{"key":"R78-20250506","doi-asserted-by":"crossref","first-page":"e10354","DOI":"10.1002\/lrh2.10354","article-title":"Establishing a Cystic Fibrosis Learning Network: interventions to promote collaboration and data-driven improvement at scale","volume":"7","author":"Ong","year":"2023","journal-title":"Learn Health Syst"},{"key":"R79-20250506","doi-asserted-by":"crossref","first-page":"e002860","DOI":"10.1136\/bmjoq-2024-002860","article-title":"Interventions to improve system-level coproduction in the Cystic Fibrosis Learning Network","volume":"13","author":"Gamel","year":"2024","journal-title":"BMJ Open Qual"},{"key":"R80-20250506","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jcf.2023.03.016","article-title":"Implementation of standardized cystic fibrosis care algorithm to improve the center data-quality improvement project international collaboration","volume":"22","author":"Gokdemir","year":"2023","journal-title":"J Cyst Fibros"},{"key":"R81-20250506","doi-asserted-by":"crossref","first-page":"e27506","DOI":"10.1002\/ppul.27506","article-title":"Implementation of cystic fibrosis responsibility, independence, self-care, education program enhances cystic fibrosis knowledge in limited resource country: results from a randomized controlled trial","volume":"60","author":"Balci","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"R82-20250506","first-page":"s17","article-title":"Guideline for the diagnosis and treatment of patients with cystic fibrosis. Update","volume":"19","year":"2021","journal-title":"Arch Argent Pediatr"},{"key":"R84-20250506","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1164\/rccm.202307-1200VP","article-title":"Affordable cystic fibrosis (CF) transmembrane conductance regulator modulator drugs for CF: all CF lives worldwide matter!","volume":"208","author":"Zampoli","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R85-20250506","doi-asserted-by":"crossref","first-page":"1163391","DOI":"10.3389\/fphar.2023.1163391","article-title":"Real-world disparities and ethical considerations with access to CFTR modulator drugs: mind the gap!","volume":"14","author":"Zampoli","year":"2023","journal-title":"Front Pharmacol"},{"key":"R86-20250506","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/ppul.27130","article-title":"Adding fuel to the fire: the growing case for global access to cystic fibrosis transmembrane conductance regulator modulator therapy","volume":"59","author":"Morrow","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"R87-20250506","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/ppul.26690","article-title":"Real-life experience with a generic formulation of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation","volume":"58","author":"Teper","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"R88-20250506","first-page":"e202202825","article-title":"Clinical and functional course of patients with cystic fibrosis treated with lumacaftor\/ivacaftor at a children's hospital. A case series","volume":"121","author":"Fern\u00e1ndez Sard\u00e1","year":"2023","journal-title":"Arch Argent Pediatr"},{"key":"R89-20250506","first-page":"00051","article-title":"Real-world outcomes of generic elexacaftor\/tezacaftor\/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost","volume":"S1569-1993","author":"Zampoli","year":"2025","journal-title":"J Cyst Fibros"},{"key":"R90-20250506","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2025.02.010","article-title":"Strategies used to access CFTR modulators in countries without reimbursement agreements","author":"Guo","year":"2025","journal-title":"J Cystic Fibros"},{"key":"R91-20250506","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/cpt.3214","article-title":"Pharmacokinetic enhancement of elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis: a cost reduction strategy to address global disparities in access","volume":"115","author":"Hong","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"R92-20250506","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcf.2023.09.003","article-title":"Global disparities in cystic fibrosis outcomes prior to CFTR modulators: a CF registries cohort study in South Africa and Canada","volume":"23","author":"Zampoli","year":"2024","journal-title":"J Cyst Fibros"},{"key":"R93-20250506","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/ppul.26954","article-title":"International disparities in diagnosis and treatment access for cystic fibrosis","volume":"59","author":"Guo","year":"2024","journal-title":"Pediatr Pulmonol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:29:01Z","timestamp":1786033741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001458","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}